{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "%load_ext autoreload\n",
    "%autoreload 2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "import sys\n",
    "import igraph as ig\n",
    "\n",
    "sys.path.append(\"/Users/jlq293/Projects/Study-1-Bibliometrics/src/main_path/\")\n",
    "\n",
    "import pandas as pd\n",
    "import networkx as nx"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# load and prep data\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "params = \"alpha0.3_k20_res0.005\"\n",
    "p = f\"../data/06-clustered-df/{params}.pkl\"\n",
    "df = pd.read_pickle(p)\n",
    "\n",
    "# print(df.columns)\n",
    "\n",
    "df_dict = {}\n",
    "for cluster in df[\"cluster_alpha0.3_k20_res0.005\"].unique():\n",
    "    # create df to key and sort by centrality\n",
    "    df_dict[cluster] = df[df[\"cluster_alpha0.3_k20_res0.005\"] == cluster].sort_values(\n",
    "        by=\"centrality_alpha0.3_k20_res0.005\", ascending=False\n",
    "    )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Cluster 91\n",
      "Electroimmobilization of MAO into a polypyrrole film and its utilization for amperometric flow detection of antidepressant drugs\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "Quantification of sertraline in human serum by high-performance thin-layer chromatography as a tool for pharmacotherapy adherence evaluation\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "Amperometric responses of CYP2D6 drug metabolism nanobiosensor for sertraline: A selective serotonin reuptake inhibitor\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "LC-MS analysis of sertraline and its active metabolite in human serum using a silica column with a non-aqueous polar mobile phase\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "Method development and validation for the simultaneous estimation of sertraline and doxofylline in pharmaceutical dosage form by RP-HPLC\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "Replacement of acetonitrile by mixtures of propylene carbonate and methanol as organic modifier in mobile phases for RPLC separation mechanism: Application to the assay of alprazolam and sertraline in combined pharmaceutical formulations\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "Quantitative analysis of sertraline in human serum by LC with fluorescence detection after pre-column derivatization with 4-chloro-7-nitrobenzofurazan\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "Preparation of molecularly imprinted copoly(acrylic acid-divinylbenzene) for extraction of environmentally relevant sertraline residues\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "Development and validation of an EI-GC/MS method for the determination of sertraline and its major metabolite desmethyl-sertraline in blood\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "Separation and determination of sertraline and its metabolite, desmethylsertraline, in mouse cerebral cortex by reversed-phase high-performance liquid chromatography\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "A novel molecular imprinted polymer layer electrode for enhanced sensitivity electrochemical determination of the antidepressant fluoxetine\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "In vitro bioequivalence study of 8 generic and 3 brands of sertraline-HCl tablets in Iran market\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "Chemical and Biological Sensors Based on Electrochemical Detection Using Conducting Electroactive Polymers\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "An electrochemical biosensor based on graphene oxide for determination of sertraline hydrochloride as an antidepressant drug\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "High performance liquid chromatographic determination of sertraline in presence of its degradation product\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "A novel self-supportive thin film based on graphene oxide reinforced chitosan nano-biocomposite for thin film microextraction of fluoxetine in biological and environmental samples\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "Cytochrome P450<inf>2D6</inf> (CYP2D6) Bioelectrode for Fluoxetine\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "Development and validation of a HPLC method for the determination of sertraline and three non-chiral related impurities\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "High sensitive voltammetric determination of paroxetine on glassy carbon electrode modified with Nafion/MWCNTs\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "Selective and highly sensitive voltammetric determination of citalopram with glassy carbon electrode\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "def cluster_title_print(df_dict, cluster, random=False, n=10):\n",
    "    if random:\n",
    "        titles = df_dict[cluster].sample(n, random_state=1887)[\"title\"].values\n",
    "    else:\n",
    "        titles = df_dict[cluster].head(n)[\"title\"].values\n",
    "    print(f\"Cluster {cluster}\")\n",
    "    for title in titles:\n",
    "        print(title)\n",
    "        print(\"# # \" * 30)\n",
    "    print(\"\\n\")\n",
    "\n",
    "\n",
    "cluster_title_print(df_dict, 91, random=True, n=20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "labels = {\n",
    "    0: \"ocd\",\n",
    "    1: \"pregnancy\",\n",
    "    2: \"determine drug concentration\",\n",
    "    3: \"chronic unpredictable mild stress in mice\",\n",
    "    4: \"serotinin receptor studies\",\n",
    "    5: \"Cytochrome P450\",\n",
    "    6: \"effect on fish\",\n",
    "    7: \"wastewater\",\n",
    "    8: \"In vivo pregnancy\",\n",
    "    9: \"Drug utilisation\",\n",
    "    10: \"PTSD\",\n",
    "    11: \"sexual dysfunction\",\n",
    "    12: \"fluoxetine; diverse\",\n",
    "    13: \"pediatric depression pharmacotherapy\",\n",
    "    14: \"forced swimming test\",\n",
    "    15: \"pharmacotherapy of depression review\",\n",
    "    16: \"Polymorphism\",\n",
    "    17: \"Serotonin syndrome\",\n",
    "    18: \"Depression treatment in carciovascular pathologies\",\n",
    "    19: \"Paroxetine, diverse\",\n",
    "    20: \"StarD\",\n",
    "    21: \"Pain\",\n",
    "    22: \"post stroke depression\",\n",
    "    23: \"inflammation and serotonin\",\n",
    "    24: \"review of antidepressant medications\",\n",
    "    25: \"weight management\",\n",
    "    26: \"geriatric use of antidepressants\",  # as ads in dementia but also agains agitation\n",
    "    27: \"Brain Derived Neurotrophic Factor\",\n",
    "    28: \"suicide risk\",\n",
    "    29: \"hippocampal neurogenesis\",\n",
    "    30: \"fear\",\n",
    "    31: \"panic disorder\",\n",
    "    32: \"treatment response biomarker\",  # where does this go within pharmacology?\n",
    "    33: \"bleeding risk\",\n",
    "    34: \"natural products\",\n",
    "    35: \"Anxiety\",\n",
    "    36: \"paroxetine binding\",\n",
    "    37: \"fracture risk\",\n",
    "    38: \"cancer\",  # the cluster is on cancer risk as well as protection\n",
    "    39: \"Dermatology\",  # psychosomatic / psychodermatology\n",
    "    40: \"covid\",  # almost exclusively fluvoxamine\n",
    "    41: \"alcoholism\",\n",
    "    42: \"irritable bowel disease\",\n",
    "    43: \"premature ejaculation\",\n",
    "    44: \"analytical chemistry\",  # determine concentration in tablets\n",
    "    45: \"sleep\",\n",
    "    46: \"eating disorders\",\n",
    "    47: \"neuroimaging\",  # uses human, in vivo, and in vitro studies. put it in any?\n",
    "    48: \"parkinson's disease\",\n",
    "    49: \"drug-drug interaction\",\n",
    "    50: \"ssri toxicity\",\n",
    "    51: \"sertraline, diverse\",\n",
    "    52: \"bipolar disorder\",\n",
    "    53: \"affective effects\",\n",
    "    54: \"fluvoxamine\",\n",
    "    55: \"hot flushes (menopause)\",\n",
    "    56: \"diabetes\",  # both as side effect and depression management in special pop\n",
    "    57: \"autoreceptors\",  # rather unclear to me\n",
    "    58: \"neuroendocrine system\",  # mixed study subjects (human, animal, in vitro)\n",
    "    59: \"cocaine addiction\",\n",
    "    60: \"venlafaxine for depression\",\n",
    "    61: \"schizophrenia\",\n",
    "    62: \"extrapyramidal side effects\",  #  movement dysfunctions\n",
    "    63: \"anxiety\",  # check merge with 35\n",
    "    64: \"clinical pharmacogenetics\",\n",
    "    65: \"synthesis and production\",\n",
    "    66: \"escitalopram for depression\",\n",
    "    67: \"epilepsy\",  # special pop and induced seizures\n",
    "    68: \"pediatric drug utilisation\",  # check merge with 9\n",
    "    69: \"autism\",\n",
    "    70: \"premenstrual syndromes\",\n",
    "    71: \"QT prolongation\",\n",
    "    72: \"chronic/prolonged use\",\n",
    "    73: \"pharmacoeconomics/health economics\",\n",
    "    74: \"ion channels\",\n",
    "    75: \"MDMA\",\n",
    "    76: \"cognitive function\",\n",
    "    77: \"serotonin transporter\",\n",
    "    78: \"pulmonary hypertension\",\n",
    "    79: \"citalopram\",\n",
    "    80: \"synthesis and compounds?\",  # need help here\n",
    "    81: \"enantiomer of citalopram\",  # someonee help me here (analyze pharmaceutical formulations in vitro to assess the composition and concentration of citalopram and its metabolites.?)\n",
    "    82: \"hyponatremia\",  # low sodium in blood\n",
    "    83: \"geriatric depression treatment\",\n",
    "    84: \"sertraline diverse\",\n",
    "    85: \"comparative studies\",\n",
    "    86: \"hepatic effects\",  # (on the liver)\n",
    "    87: \"borderline personality disorder\",\n",
    "    88: \"compulsions? body dysmorphic disorder? \",\n",
    "    89: \"gut microbiota\",\n",
    "    90: \"withdrawal symptoms\",\n",
    "    91: \"drug quantification (sertraline)\",\n",
    "    92: \"lactation\",  # put in pregnancy category?\n",
    "    93: \"pediatric anxiety\",\n",
    "    94: \"Neurosteroids\",\n",
    "    95: \"astrocytic receptors\",\n",
    "    96: \"Neurological Disorders and Emotional Dysregulation\",\n",
    "    97: \"male fertility\",  # testicular tissue and sperm quality\n",
    "    98: \"vitamin supplements for depression\",  # folic acid\",vitamin B12 and B9\n",
    "    99: \"seasonal affective disorder\",  # light therapy\n",
    "}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_keys(['Pharmacology', 'Disorder/Disease', 'Safety', 'Study type', 'Special Populations', 'Drug', 'Other'])"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tree = {\n",
    "    \"Pharmacology\": {\n",
    "        \"Pharmacokinetics\": {\n",
    "            \"Analytical Methods\": {\"clusters\": [2, 44, 81, 91]},\n",
    "            \"Cytochromes\": {\"clusters\": [5]},\n",
    "        },\n",
    "        \"Pharmacodynamics\": {\n",
    "            \"Metabolism\": {\"clusters\": []},\n",
    "            \"Mechanism of Action\": {\n",
    "                \"Receptor studies\": [4, 36, 57],\n",
    "                \"Animal models\": [3, 14],\n",
    "                \"hippocampal neurogenesis\": [29],\n",
    "                \"neuroimaging\": [47],\n",
    "                \"neuroendocrine system\": [47],\n",
    "                \"ion channels\": [74],\n",
    "                \"serotonin transporter\": [77],\n",
    "                \"synthesis and compounds?\": [80],\n",
    "                \"gut microbiota\": [89],\n",
    "                \"neurosteroids\": [94],\n",
    "                \"astrocytic receptors\": [95],\n",
    "            },\n",
    "            \"inflammation\": [23],\n",
    "            \"fear\": [30],\n",
    "            \"prolonged use\": [72],\n",
    "            \"pulmonary hypertension\": [78],\n",
    "            \"male fertility\": [97],\n",
    "        },\n",
    "        \"Pharmacogenetics\": {\n",
    "            \"Polymorphism\": {\"clusters\": [16]},\n",
    "            \"BDNF\": {\"clusters\": [27]},\n",
    "            \"clinical pharmacogenetics\": {\"clusters\": [64]},\n",
    "        },\n",
    "        \"Pharmacoepidemiology\": {\"Drug utilisation\": {\"clusters\": [9, 68]}},\n",
    "        \"Review\": {\"Review of antidepressant medications\": [24]},\n",
    "    },\n",
    "    \"Disorder/Disease\": {\n",
    "        \"Depression\": {\n",
    "            \"clusters\": [3, 13, 15, 16, 18, 20, 22, 28, 32, 60, 64, 66, 73, 83, 85, 98]\n",
    "        },\n",
    "        \"Anxiety\": {\"clusters\": [30, 35, 63, 93]},\n",
    "        \"OCD\": {\"clusters\": [0]},\n",
    "        \"PTSD\": {\"clusters\": [10]},\n",
    "        \"Panic Disorder\": {\"clusters\": [31]},\n",
    "        \"Pain\": {\"clusters\": [21]},\n",
    "        \"Inflammations\": {\"clusters\": [23]},\n",
    "        \"Weight Management\": {\"clusters\": [25]},\n",
    "        \"Agitation in dementia\": {\"clusters\": [26]},\n",
    "        \"Dermatology\": {\"clusters\": [39]},\n",
    "        \"Covid\": {\"clusters\": [40]},\n",
    "        \"alcohol dependence\": {\"clusters\": [41]},\n",
    "        \"irretable bowel disease\": {\"clusters\": [42]},\n",
    "        \"premature ejaculation\": {\"clusters\": [43]},\n",
    "        \"sleep\": {\"clusters\": [45]},\n",
    "        \"eating disorders\": {\"clusters\": [46]},\n",
    "        \"bipolar disorder\": {\"clusters\": [46]},\n",
    "        \"hot flushes\": {\"clusters\": [55]},\n",
    "        \"diabetes\": {\"clusters\": [56]},\n",
    "        \"cocaine addiction\": {\"clusters\": [59]},\n",
    "        \"schizophrenia\": {\"clusters\": [61]},\n",
    "        \"epilepsy\": {\"clusters\": [67]},\n",
    "        \"autism\": {\"clusters\": [69]},\n",
    "        \"premenstrual syndromes\": {\"clusters\": [70]},\n",
    "        \"Borderline Personlaity Disorder\": {\"clusters\": [87]},\n",
    "        \"Neurological Disorders\": {\"clusters\": [96]},\n",
    "        \"seasonal affective disorder\": {\"clusters\": [99]},\n",
    "    },\n",
    "    \"Safety\": {  # or pharmacovigilance?\n",
    "        \"Serotonin syndrom\": {\"clusters\": [17]},\n",
    "        \"Sexual dysfunction\": {\"clusters\": [11]},\n",
    "        \"Suicide\": {\"clusters\": [13, 28]},\n",
    "        \"Bleeding\": {\"clusters\": [33]},\n",
    "        \"Fracture\": {\"clusters\": [37]},\n",
    "        \"Cancer\": {\"clusters\": [38]},\n",
    "        \"SSRI Toxicity\": {\"clusters\": [50]},\n",
    "        \"diabetes\": {\"clusters\": [56]},\n",
    "        \"extrapyramidal side effects\": {\"clusters\": [62]},\n",
    "        \"qt prolongation\": {\"clusters\": [71]},\n",
    "        \"prolonged use\": {\"clusters\": [72]},\n",
    "        \"hyponatremia\": {\"clusters\": [82]},\n",
    "        \"hepatic effects\": {\"clusters\": [86]},\n",
    "        \"withdrawal\": {\"clusters\": [86]},\n",
    "        \"male fertility\": {\"clusters\"}[97],\n",
    "    },\n",
    "    \"Study type\": {\n",
    "        \"Clinical Focus\": {\n",
    "            \"clusters\": [\n",
    "                0,\n",
    "                1,\n",
    "                10,\n",
    "                11,\n",
    "                13,\n",
    "                16,\n",
    "                17,\n",
    "                18,\n",
    "                20,\n",
    "                21,\n",
    "                22,\n",
    "                23,\n",
    "                24,\n",
    "                25,\n",
    "                26,\n",
    "                28,\n",
    "                31,\n",
    "                32,\n",
    "                33,\n",
    "                35,\n",
    "                37,\n",
    "                38,\n",
    "                39,\n",
    "                41,\n",
    "                43,\n",
    "                45,\n",
    "                46,\n",
    "                48,\n",
    "                49,\n",
    "                50,\n",
    "                54,\n",
    "                55,\n",
    "                56,\n",
    "                60,\n",
    "                61,\n",
    "                62,\n",
    "                63,\n",
    "                64,\n",
    "                66,\n",
    "                67,\n",
    "                68,\n",
    "                69,\n",
    "                71,\n",
    "                76,\n",
    "                79,\n",
    "                82,\n",
    "                83,\n",
    "                84,\n",
    "                85,\n",
    "                86,\n",
    "                87,\n",
    "                90,\n",
    "                92,\n",
    "                93,\n",
    "                96,\n",
    "                98,\n",
    "            ]\n",
    "        },\n",
    "        \"Preclinical Focus\": {\n",
    "            \"animal models of disorders\": {\n",
    "                \"chronic unpredictable mild stress\": [3],\n",
    "                \"forced swimming test\": [14],\n",
    "            },\n",
    "            \"in vivo\": [\n",
    "                4,\n",
    "                5,\n",
    "                8,\n",
    "                21,\n",
    "                27,\n",
    "                29,\n",
    "                30,\n",
    "                34,\n",
    "                36,\n",
    "                57,\n",
    "                59,\n",
    "                72,\n",
    "                75,\n",
    "                77,\n",
    "                78,\n",
    "                89,\n",
    "                94,\n",
    "                97,\n",
    "                99,\n",
    "            ],\n",
    "            \"in vitro\": [44, 74, 81, 91],\n",
    "        },\n",
    "        \"Environmental Focus\": {\n",
    "            \"Fish\": [6],\n",
    "            \"Wastewater\": [7],\n",
    "        },\n",
    "        \"Reviews\": [\n",
    "            15,\n",
    "            24,\n",
    "            35,\n",
    "            51,\n",
    "            52,\n",
    "            55,\n",
    "            60,\n",
    "            63,\n",
    "            66,\n",
    "            68,\n",
    "            69,\n",
    "            76,\n",
    "            79,\n",
    "            83,\n",
    "            84,\n",
    "            85,\n",
    "            87,\n",
    "            90,\n",
    "            92,\n",
    "            93,\n",
    "        ],\n",
    "        \"Comparative studies\": {\"clusters\": [20, 54]},\n",
    "    },\n",
    "    \"Special Populations\": {\n",
    "        \"pregnancy\": {\"clusters\": [1, 8, 92]},  # 92 is lactation\n",
    "        \"pediatrics\": {\"clusters\": [13, 28, 93]},\n",
    "        \"cariovascur pathologies\": {\"clusters\": [18]},\n",
    "        \"post stroke\": {\"clusters\": [22]},\n",
    "        \"geriatrics\": {\n",
    "            \"clusters\": [\n",
    "                26,\n",
    "                37,\n",
    "                48,\n",
    "                49,\n",
    "                76,\n",
    "                82,  # mainly on a side effect that is more common in elderly\n",
    "                83,\n",
    "            ]\n",
    "        },\n",
    "        # \"cancer\": {\"clusters\": [38]}, it is in safety\n",
    "        \"diabetes\": {\"clusters\": [56]},\n",
    "    },\n",
    "    \"Drug\": {\n",
    "        \"Fluoxetine\": {\"clusters\": [12]},\n",
    "        \"Paroxetine\": {\"clusters\": [19, 36]},\n",
    "        \"Sertraline\": {\"clusters\": [51, 84]},\n",
    "        \"Fluvoxamine\": {\"clusters\": [54]},\n",
    "        \"Citalopram\": {\"clusters\": [79]},\n",
    "        \"Escitalopram\": {\"clusters\": [66]},\n",
    "        \"Venlafaxine\": {\"clusters\": [60]},\n",
    "    },\n",
    "    \"Other\": {\n",
    "        \"Natural Products\": {\"clusters\": [34]},\n",
    "        \"affective effects\": {\"clusters\": [53]},\n",
    "        \"synthesis and production\": {\"clusters\": [65]},\n",
    "        \"health economics\": {\"clusters\": [73]},\n",
    "    },\n",
    "}\n",
    "\n",
    "tree.keys()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Category Building :\n",
    "\n",
    "## Pharmacology\n",
    "\n",
    "### Subcategories:\n",
    "\n",
    "1. Pharmacokinetics\n",
    "2. Pharmacodynamics\n",
    "   1. Forced Swimming Test\n",
    "3. Pharmacogenetics\n",
    "4. Toxicology?\n",
    "5. Pharmacoepidemiology?\n",
    "\n",
    "## Treatment in Special Populations\n",
    "\n",
    "### Subcategories:\n",
    "\n",
    "1. Pregnant women\n",
    "2. Children\n",
    "3. Elderly\n",
    "4. Disease states (e.g. renal failure, diabetes, cancer, parkinsons, etc.)\n",
    "\n",
    "## Disorders/Diseases (can also be interpreted as expansion of indication)\n",
    "\n",
    "### Subcategories:\n",
    "\n",
    "1. Depression\n",
    "2. Anxiety\n",
    "3. Schizophrenia\n",
    "4. Bipolar disorder\n",
    "5. OCD\n",
    "6. Pain\n",
    "7. Sleep\n",
    "\n",
    "## Drug Focused\n",
    "\n",
    "### Subcategories:\n",
    "\n",
    "1. Fluoxetine\n",
    "2. Sertraline\n",
    "   etc\n",
    "\n",
    "## Animal Focused\n",
    "\n",
    "### Subcategories:\n",
    "\n",
    "1. chronic unpredictable mild stress in mice\n",
    "2. forced swimming test\n",
    "\n",
    "## Safety\n",
    "\n",
    "### Subcategories:\n",
    "\n",
    "1. Bleeding\n",
    "2. Cardiac\n",
    "3. Withdrawal\n",
    "\n",
    "# Open Questions:\n",
    "\n",
    "1. How to deal with non-exclusive categories?\n",
    "\n",
    "   1.1 Multiple categories per paper?\n",
    "\n",
    "2. Using all clusters?\n",
    "3. Merging some clusters?\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Study1Analysis",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
